OptiNose, Inc. logo

OptiNose, Inc.

NASDAQ:OPTN

Overview | Financials
Company Name OptiNose, Inc.
Symbol OPTN
Currency USD
Price 1.24
Market Cap 179,600,360
Dividend Yield 0%
52-week-range 0.8 - 2.1
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Ramy A. Mahmoud M.D., M.P.H.
Website https://www.optinose.com

An error occurred while fetching data.

About OptiNose, Inc.

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment

Related Stocks

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

5 USD

Longeveron Inc. logo

Longeveron Inc.

LGVN

1.81 USD

Biomea Fusion, Inc. logo

Biomea Fusion, Inc.

BMEA

4.63 USD

Omeros Corporation logo

Omeros Corporation

OMER

3.77 USD

Chimerix, Inc. logo

Chimerix, Inc.

CMRX

0.933 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

2.98 USD

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

1.37 USD

Financials

Numbers are in millions USD

Numbers are in millions USD